* Outset Medical Inc OM.OQ OM.O is expected to show a
rise in
quarterly revenue when it reports results on February 13.
* The San Jose California-based company is expected to
report a
9.8% increase in revenue to $30.922 million from $28.15 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data. The company's guidance on January 9
2023, for the period ended December 31, was for revenue of
$31.500 million.
* Refinitiv's mean analyst estimate for Outset Medical Inc
is for
a loss of 86 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Outset
Medical
Inc is $31, above its last closing price of $28.59.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 -0.84 -0.81 -0.85 Missed -4.9
Jun. 30 2022 -0.68 -0.70 -0.92 Missed -31.8
Mar. 31 2022 -0.71 -0.72 -0.78 Missed -8.3
Dec. 31 2021 -0.75 -0.77 -0.87 Missed -13.4
Sep. -0.77 -0.73 -0.65 Beat 11
30 2021
Jun. 30 2021 -0.69 -0.70 -0.66 Beat 5.4
Mar. 31 2021 -0.80 -0.81 -0.70 Beat 13.7
Dec. 31 2020 -0.66 -0.66 -0.75 Missed -13
This summary was machine generated February 11 at 00:22 GMT.
All figures in US dollars unless otherwise stated